0000899243-18-010071.txt : 20180412 0000899243-18-010071.hdr.sgml : 20180412 20180412160856 ACCESSION NUMBER: 0000899243-18-010071 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180411 FILED AS OF DATE: 20180412 DATE AS OF CHANGE: 20180412 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Grossi Federico CENTRAL INDEX KEY: 0001720634 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38276 FILM NUMBER: 18752194 MAIL ADDRESS: STREET 1: C/O APELLIS PHARMACEUTICALS, INC. STREET 2: 6400 WESTWIND WAY, SUITE A CITY: CRESTWOOD STATE: KY ZIP: 40014 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Apellis Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001492422 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 271537290 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6400 WESTWIND WAY STREET 2: SUITE A CITY: CRESTWOOD STATE: KY ZIP: 40014 BUSINESS PHONE: 502-241-4114 MAIL ADDRESS: STREET 1: 6400 WESTWIND WAY STREET 2: SUITE A CITY: CRESTWOOD STATE: KY ZIP: 40014 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-04-11 0 0001492422 Apellis Pharmaceuticals, Inc. APLS 0001720634 Grossi Federico C/O APELLIS PHARMACEUTICALS, INC 6400 WESTWIND WAY, SUITE A CRESTWOOD KY 40014 0 1 0 0 See Remarks Common Stock 2018-04-11 4 M 0 8500 3.20 A 8500 D Stock Option (right to buy) 3.20 2018-04-11 4 M 0 8500 0.00 D 2024-12-11 Common Stock 8500 61823 D This option was granted on December 12, 2014 and has vested as to 25% of the shares underlying the options on the first anniversary of the grant, with the remaining 75% of the shares underlying the options vesting in equal monthly installments thereafter through the fourth anniversary of the grant, subject to continued service. Executive Vice President - Clinical Development /s/ David Watson, attorney-in-fact for Federico Grossi 2018-04-12